Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00703573 · ClinicalTrials.gov registry record · Phase 2
A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis
A Phase 2 study, sponsored by Shionogi.
- Completed
- Registry status
- Phase 2
- Development phase
- 209
- Enrollment target
NCT00703573 is a Phase 2 study that has completed, run by Shionogi. The registered enrollment target is 209 participants.
The verdict
NCT00703573, a Phase 2 study, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 209 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of 2 doses of S-777469 in patients with atopic dermatitis.
Interventions
- DRUG Placebo
- DRUG S-777469 400 mg
- DRUG S-777469 800 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00703573
The ClinicalTrials.gov registry entry for NCT00703573 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00703573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00703573 about?
NCT00703573 is a clinical study titled "A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis". The purpose of this study is to evaluate the safety and efficacy of 2 doses of S-777469 in patients with atopic dermatitis.
What is the current status of trial NCT00703573?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 209 participants. The study started on 2008-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00703573?
The interventions under investigation include: Placebo (DRUG), S-777469 400 mg (DRUG), S-777469 800 mg (DRUG).
Who is sponsoring clinical trial NCT00703573?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.